Cancer stem cells: are we missing the target? (Q35752241)

10 August 2017

1 reference

title

Cancer stem cells: are we missing the target? (English)

1 reference

10 August 2017

neoplastic stem cells

1 reference

Richard J Jones

1

1 reference

10 August 2017

William H Matsui

series ordinal

2

1 reference

10 August 2017

B Douglas Smith

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Journal of the National Cancer Institute

10 August 2017

1 reference

10 August 2017

96

1 reference

10 August 2017

8

1 reference

10 August 2017

583-585

1 reference

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

10 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Quantitative assessment of gene expression in highly purified hematopoietic cells using real-time reverse transcriptase polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

The specific enhancement of interferon alpha induced growth inhibition by BCR/ABL only occurs in multipotent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Characterization of clonogenic multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH095

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJH095

1 reference

release_idw5btuyqzdrtdvayp6iki2jyu

10 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/idw5btuyqzdrtdvayp6iki2jyu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference